| International Union of Pharmacology. LIII. Nomenclature and molecular relationships of voltage-gated potassium channels GA Gutman, KG Chandy, S Grissmer, M Lazdunski, D Mckinnon, ... Pharmacological reviews 57 (4), 473-508, 2005 | 1304 | 2005 |
| Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1. 1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines. S Grissmer, AN Nguyen, J Aiyar, DC Hanson, RJ Mather, GA Gutman, ... Molecular pharmacology 45 (6), 1227-1234, 1994 | 1024 | 1994 |
| Voltage-gated K+ channels in human T lymphocytes: a role in mitogenesis? TE DeCoursey, KG Chandy, S Gupta, MD Cahalan Nature 307 (5950), 465-468, 1984 | 933 | 1984 |
| Design of a potent and selective inhibitor of the intermediate-conductance Ca2+-activated K+ channel, IKCa1: A potential immunosuppressant H Wulff, MJ Miller, W Hänsel, S Grissmer, MD Cahalan, KG Chandy Proceedings of the National Academy of Sciences 97 (14), 8151-8156, 2000 | 761 | 2000 |
| The functional network of ion channels in T lymphocytes MD Cahalan, KG Chandy Immunological reviews 231 (1), 59-87, 2009 | 710 | 2009 |
| Kv1. 3 channels are a therapeutic target for T cell-mediated autoimmune diseases C Beeton, H Wulff, NE Standifer, P Azam, KM Mullen, MW Pennington, ... Proceedings of the National Academy of Sciences 103 (46), 17414-17419, 2006 | 630 | 2006 |
| The voltage-gated Kv1.3 K+ channel in effector memory T cells as new target for MS H Wulff, PA Calabresi, R Allie, S Yun, M Pennington, C Beeton, ... The Journal of clinical investigation 111 (11), 1703-1713, 2003 | 568 | 2003 |
| K+ channels as targets for specific immunomodulation KG Chandy, H Wulff, C Beeton, M Pennington, GA Gutman, MD Cahalan Trends in pharmacological sciences 25 (5), 280-289, 2004 | 567 | 2004 |
| International Union of Pharmacology. LII. Nomenclature and molecular relationships of calcium-activated potassium channels AD Wei, GA Gutman, R Aldrich, KG Chandy, S Grissmer, H Wulff Pharmacological reviews 57 (4), 463-472, 2005 | 523 | 2005 |
| Up-regulation of the IKCa1 potassium channel during T-cell activation: molecular mechanism and functional consequences S Ghanshani, H Wulff, MJ Miller, H Rohm, A Neben, GA Gutman, ... Journal of Biological Chemistry 275 (47), 37137-37149, 2000 | 519 | 2000 |
| A voltage‐gated potassium channel in human T lymphocytes. MD Cahalan, KG Chandy, TE DeCoursey, S Gupta The Journal of physiology 358 (1), 197-237, 1985 | 515 | 1985 |
| A unified nomenclature for short-chain peptides isolated from scorpion venoms: α-KTx molecular subfamilies J Tytgat, KG Chandy, ML Garcia, GA Gutman, MF Martin-Eauclaire, ... Trends in pharmacological sciences 20 (11), 444-447, 1999 | 494 | 1999 |
| International Union of Pharmacology. XLI. Compendium of voltage-gated ion channels: potassium channels GA Gutman, KG Chandy, JP Adelman, J Aiyar, DA Bayliss, DE Clapham, ... Pharmacological reviews 55 (4), 583-586, 2003 | 466 | 2003 |
| Selective blockade of T lymphocyte K+ channels ameliorates experimental autoimmune encephalomyelitis, a model for multiple sclerosis C Beeton, H Wulff, J Barbaria, O Clot-Faybesse, M Pennington, D Bernard, ... Proceedings of the national academy of sciences 98 (24), 13942-13947, 2001 | 455 | 2001 |
| Voltage-gated potassium channels are required for human T lymphocyte activation. KG Chandy, TE DeCoursey, MD Cahalan, C McLaughlin, S Gupta The Journal of experimental medicine 160 (2), 369-385, 1984 | 453 | 1984 |
| Calmodulin mediates calcium-dependent activation of the intermediate conductance KCa channel, IKCa1 CM Fanger, S Ghanshani, NJ Logsdon, H Rauer, K Kalman, J Zhou, ... Journal of Biological Chemistry 274 (9), 5746-5754, 1999 | 431 | 1999 |
| International Union of Pharmacology. XL. Compendium of voltage-gated ion channels: calcium channels WA Catterall, J Striessnig, TP Snutch, E Perez-Reyes Pharmacological reviews 55 (4), 579-581, 2003 | 362 | 2003 |
| ShK-Dap22, a potent Kv1. 3-specific immunosuppressive polypeptide K Kalman, MW Pennington, MD Lanigan, A Nguyen, H Rauer, V Mahnir, ... Journal of Biological Chemistry 273 (49), 32697-32707, 1998 | 356 | 1998 |
| Targeting effector memory T cells with a selective peptide inhibitor of Kv1. 3 channels for therapy of autoimmune diseases C Beeton, MW Pennington, H Wulff, S Singh, D Nugent, G Crossley, ... Molecular pharmacology 67 (4), 1369-1381, 2005 | 350 | 2005 |
| Topology of the pore-region of a K+ channel revealed by the NMR-derived structures of scorpion toxins J Aiyar, JM Withka, JP Rizzi, DH Singleton, GC Andrews, W Lin, J Boyd, ... Neuron 15 (5), 1169-1181, 1995 | 342 | 1995 |
